Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy

2006 ◽  
Vol 13 (9) ◽  
pp. 1197-1201 ◽  
Author(s):  
TAKATSUGU OKEGAWA ◽  
MANAMI KINJO ◽  
KIKUO NUTAHARA ◽  
EIJI HIGASHIHARA
Keyword(s):  
Prostate Cancer ◽  
Prognostic Factor ◽  
Serum Level ◽  
Cancer Patients ◽  
Endocrine Therapy ◽  
Metastatic Prostate Cancer ◽  
Pretreatment Serum

scholarly journals Size of pelvic bone metastasis as a significant prognostic factor for metastatic prostate cancer patients

2020 ◽  
Vol 38 (10) ◽  
pp. 993-996
Author(s):  
Toyokazu Hayakawa ◽  
Ken-ichi Tabata ◽  
Hideyasu Tsumura ◽  
Shogo Kawakami ◽  
Takeo Katakura ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Bone Metastasis ◽  
Prognostic Factor ◽  
Cancer Patients ◽  
Metastatic Prostate Cancer ◽  
Pelvic Bone ◽  
Significant Prognostic Factor

Changes in Chromogranin A Serum Levels During Endocrine Therapy in Metastatic Prostate Cancer Patients

2005 ◽  
Vol 48 (2) ◽  
pp. 224-230 ◽  
Author(s):  
Tetsuro Sasaki ◽  
Akira Komiya ◽  
Hiroyoshi Suzuki ◽  
Masaki Shimbo ◽  
Takeshi Ueda ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Endocrine Therapy ◽  
Chromogranin A ◽  
Metastatic Prostate Cancer ◽  
Serum Levels

scholarly journals Pretreatment Serum Level of Testosterone as a Prognostic Factor in Japanese Men with Hormonally Treated Stage D2 Prostate Cancer.

2001 ◽  
Vol 48 (5) ◽  
pp. 573-578 ◽  
Author(s):  
TAKASHI IMAMOTO ◽  
HIROYOSHI SUZUKI ◽  
KOICIRO AKAKURA ◽  
AKIRA KOMIYA ◽  
HIROSHI NAKAMACHI ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prognostic Factor ◽  
Serum Level ◽  
Japanese Men ◽  
Pretreatment Serum
Sign in / Sign up

Export Citation Format

Share Document